DermTech International

Events

By 2010, current estimates indicate 1:50 people will be diagnosed with melanoma during their lifetime.
Melanoma is the most common cancer in women aged 25-29.
If melanoma is treated before it spreads it is 95-99% curable

A Non-invasive Genomic Assay for Detection of Melanoma
Wachsman W, Palmer T, Wei M, Walls L, Norman S, Rabinovitz H and Chang S. (2009) 7th World Congress on Melanoma Annual Meeting, Vienna, Austria, May 12-16, 2009.
Development of a Non-invasive Genomic Assay to Detect Melanoma
Wachsman W, Palmer T, Walls L and Chang S (2009) Society for Investigative Dermatology, Montreal, Canada, May 6-9
Epidermal Genetic Information Retrieval (EGIR) Enables a Genomic Assay for Noninvasive Detection of Melanoma
Wachsman W, Hata T, Walls L, Palmer T, Wei M, Rabinovitz H and Chang S. (2008) Association for Molecular Pathology 2008 Annual Meeting, Grapevine, TX, October 31 –November 2, 2008
A Non-invasive Genomic Assay for the Detection of Melanoma in Suspicious Pigmented Nevi Chang S, Rabinovitz H, Bastian B, Hata T, Walls L, Palmer T and Wachsman W.
(2008) AACR annual meeting, San Diego, CA. April 12-16, 2008
A Non-invasive EGIR-based Genomic Assay Discriminates Melanoma from Atypical Nevi.
Wachsman W, Zapala M, Udall D, Paik A, Hata T, Walls L, Wong R, Schork N, Bastian B, Chang S. (2007) 4th International Melanoma Congress, New York City, November 1-4, 2007
Differentiation of Melanoma from Dysplastic Nevi in Suspicious Pigmented Skin Lesions by Non-invasive Tape Stripping
Society for Investigative Dermatology Annual Meeting, Los Angeles, May 2007